[go: up one dir, main page]

JPS61291595A - Production of 2'-0-methylated rna - Google Patents

Production of 2'-0-methylated rna

Info

Publication number
JPS61291595A
JPS61291595A JP60133182A JP13318285A JPS61291595A JP S61291595 A JPS61291595 A JP S61291595A JP 60133182 A JP60133182 A JP 60133182A JP 13318285 A JP13318285 A JP 13318285A JP S61291595 A JPS61291595 A JP S61291595A
Authority
JP
Japan
Prior art keywords
methyl
group
protected
rna
methyluridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60133182A
Other languages
Japanese (ja)
Inventor
Eiko Otsuka
栄子 大塚
Hideo Inoue
英夫 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP60133182A priority Critical patent/JPS61291595A/en
Publication of JPS61291595A publication Critical patent/JPS61291595A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3212'-O-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

PURPOSE:To obtain the titled nucleic acid probe to form stable complex with RNA or DNA, by bonding successively 5'-OH and 3'-OH of riboside such as 2'-O-methyluridine, etc., through phosphoric acid and removing the protecting group. CONSTITUTION:5'-OH and 3'-OH of a riboside selected from 2'-O-methyluridine, 2'-O-methyl-N<4>-protected cytidine, 2'-O-methyl-N<6>-protected-adenosine and 2'-O- methyl-N<2>-protected guanosine are successively bonded (condensed) through phosphoric acid by phosphoric acid triester method or phosphorus acid triester method in such a way that preset sequence (e.g., sequence of partial structure of messenger RNA, etc.) order is obtained and the protecting group is removed to give the aimed compound. The condensation reaction is carried out on a solid-phase carrier such as silica gel, polystyrene, porous glass, etc., and the reaction product is separated from the carrier after the condensation reaction is over, isolated and purified by column chromatography, etc.

Description

【発明の詳細な説明】 産業上の利用分野 この発明は、2’−0−メチル化RNA (以下「メチ
ルRNA Jと記す)に関する。メチルRNAは、相補
的な塩基配列を有するRNA又はDNAと安定な複合体
を形成し、メツセンジャーRNA又は染色体遺伝子よシ
目的のRNA又は染色体遺伝子区分を選別する際の勝れ
たグローブとなる〇 従来の技術 メツセンジャーRNA又は染色体遺伝子よシ目的のRN
A又は染色体遺伝子区分を選別する際のグローブとして
従来DNAが使用されている。しかるにグローブDNA
とそれに相補性を有するRNA又はDNAとの複合体の
安定性は、必ずしも充分でなく、緩和な条件下でも解離
し又はグローブDNAと目的RNA又はDNAの一方の
一部の塩基配列が他方と部分的に異なる場合には、複合
体を形成しないことがある。また従来の天然型プローブ
は核酸分解酵素によシ分解を受けることなど問題点を有
していた。また2’−0−メチル化RNAは種々のRN
A分解酵素の基質にならないことやヌクレアーゼ、ホス
ホジェステラーゼ、ホスホリラーゼに対して抵抗性を示
すのでグローブとして用いる際に、大きな利点を有して
いる。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application This invention relates to 2'-0-methylated RNA (hereinafter referred to as "methyl RNA J"). Methyl RNA is a type of RNA or DNA that has a complementary base sequence. Forms a stable complex and becomes an excellent glove when selecting the desired RNA or chromosomal gene segment from Messenger RNA or chromosomal genes 〇 Conventional technology Messenger RNA or chromosomal genes from the desired RNA
Conventionally, DNA has been used as a glove for selecting A or chromosomal gene divisions. However, globe DNA
The stability of the complex between DNA and RNA or DNA that is complementary to it is not necessarily sufficient; it may dissociate even under mild conditions, or the base sequence of one part of the globe DNA and the target RNA or DNA may be partially different from that of the other. If they are physically different, they may not form a complex. Furthermore, conventional natural probes have had problems such as being subject to cycleolysis by nucleolytic enzymes. In addition, 2'-0-methylated RNA is
It has great advantages when used as gloves because it does not serve as a substrate for A-degrading enzyme and exhibits resistance to nuclease, phosphogesterase, and phosphorylase.

発明が解決しようとする問題点 従ってこの発明の目的は、RNA又はDNAとよシ安定
な複合体を形成する核酸グローブを得、これを製造する
方法を見い出すことにある。
Problems to be Solved by the Invention It is therefore an object of the present invention to obtain nucleic acid globes that form stable complexes with RNA or DNA and to find a method for producing them.

問題点を解決するための手段 本発明者らは、叙上の問題を解決するため種々研究の結
果、2′−〇−メチルウリジン、2′−O−メチル−N
4−保護−シチジン、2′−0−メチル−N6−保護−
アデノシン及び2′−0−メチル−N2−保護−グアノ
シンよシ選ばれるすがシトを予め定められた配列順序に
なるようにりがシトの5′−水酸基と3′−水酸基とを
リン酸を介して順次結合せしめ、保護基を脱離せしめる
ことによシ予め定められた塩基配列を有する2′−〇−
メチル化RNAの製造することに成功した。しかも得ら
れた2′−〇−メチル化RNAはそれと相補的塩基配列
を有するDNA及びRNAと前記目的を充分に達成する
ハイブリッド形成反応をすることを認めた。
Means for Solving the Problems In order to solve the above-mentioned problems, the present inventors, as a result of various studies, found that 2'-0-methyluridine, 2'-O-methyl-N
4-protected-cytidine, 2'-0-methyl-N6-protected-
Adenosine and 2'-0-methyl-N2-protected-guanosine are selected by adding phosphoric acid to the 5'-hydroxyl and 3'-hydroxyl groups of the cytosine in a predetermined arrangement order. 2′-〇- having a predetermined base sequence by sequentially bonding through
We succeeded in producing methylated RNA. Furthermore, it has been found that the obtained 2'-0-methylated RNA undergoes a hybridization reaction with DNA and RNA having complementary base sequences to sufficiently achieve the above-mentioned purpose.

2′−〇−メチルウリジンの製法 ウリジンを1.1,3.3−テトライソグロビルシジリ
ル基のよう713’、5’水酸基を同時に保護できる保
護基で保護し、次いでつ2シルのN3位を例えばベンゾ
イル基のようなアシル基で保護し、更に2′水酸基をヨ
ウ化メチルと酸化銀を用いて、ベンゼンのような有機溶
媒中でメチル化し、3’、5’ −0−保@2’−0−
メチルウリジンを得ることができる。
Process for producing 2'-〇-methyluridine Uridine is protected with a protecting group that can simultaneously protect the 713' and 5' hydroxyl groups, such as the 1,1,3,3-tetraisoglovir sidilyl group, and then the 2-sil N3 The 2' hydroxyl group is protected with an acyl group such as benzoyl, and the 2' hydroxyl group is methylated using methyl iodide and silver oxide in an organic solvent such as benzene to protect the 3',5'-0-protection@ 2'-0-
Methyluridine can be obtained.

ヨウ化メチルと酸化銀を用いてメチル化を行なう場合、
5′水酸基の保護基としては、ジメトキシトリチル基、
モノメトキシトリチル基、トリチル基、トリチルオキシ
アセチル基、レプリニル基、ジブロモメチルベンゾイル
基又はターシャリ−ブチルジメチルシリル基などの保護
基を用い、3′水酸基をターシャリ−ブチルジメチルシ
リル基、オルトニトロベンジル基などで保護しておきメ
チル化を行なうこともできる。
When performing methylation using methyl iodide and silver oxide,
As a protecting group for 5' hydroxyl group, dimethoxytrityl group,
Using a protecting group such as a monomethoxytrityl group, trityl group, trityloxyacetyl group, reprinyl group, dibromomethylbenzoyl group or tert-butyldimethylsilyl group, the 3' hydroxyl group can be converted to a tert-butyldimethylsilyl group, ortho-nitrobenzyl group, etc. Methylation can also be performed after protection with

又、5′水酸基のみを上記保護基で保護し、塩化第一錫
とジアゾメタンを用いて2′水酸基をメチル化し、3′
体と分離することもできる。1,1,3.3−テトライ
ングロビルジシリル基、又はターシャリ−ブチルジメチ
ルシリル基はフッ化n−テトラブチルアンモニウム若し
くは、0.5規定塩化水素を用い、ジオキサン、テトラ
ヒドロフランなどの有機溶媒中で反応を行ない保護基を
除去することができる。更に塩基部のアシル基はアンモ
ニア水のような塩基性条件で脱係!Iができ、これらの
脱保護反応条件では2’−0−メチル基は安定である。
Alternatively, only the 5' hydroxyl group is protected with the above protecting group, the 2' hydroxyl group is methylated using stannous chloride and diazomethane, and the 3' hydroxyl group is methylated using stannous chloride and diazomethane.
It can also be separated from the body. 1,1,3.3-tetrainglobyldisilyl group or tert-butyldimethylsilyl group is reacted with n-tetrabutylammonium fluoride or 0.5N hydrogen chloride in an organic solvent such as dioxane or tetrahydrofuran. The protecting group can be removed by performing Furthermore, the acyl group in the base part is released under basic conditions such as aqueous ammonia! I, and the 2'-0-methyl group is stable under these deprotection reaction conditions.

不純物を含む2′−〇−メチルウリジンは、メタノール
と酢酸エチルの混合溶媒中から再結晶化し精製すること
ができる。
2'-0-methyluridine containing impurities can be purified by recrystallization from a mixed solvent of methanol and ethyl acetate.

シチジン、のN4位のアミノ基は、アニソイル基やベン
ゾイル基のよりなアシル基で保護しておき、2’−〇−
メチルウリジンの製法と同様な方法で2′−〇−メチル
〜N保護−シチジンを製造することができる。又、2’
−O−メチル−N保護シチジンが不純物を含んでいる場
合は、エタノール中よシ再結晶し精製することができる
The amino group at the N4 position of cytidine is protected with an acyl group such as anisoyl group or benzoyl group, and the 2'-〇-
2'-0-Methyl to N-protected-cytidine can be produced by a method similar to that for producing methyluridine. Also, 2'
If the -O-methyl-N-protected cytidine contains impurities, it can be purified by recrystallization in ethanol.

2’−0−メチル−N6保護−ア≠ノシンの製法6−ク
ロロ−9−(β−D−リ?72ノシル)fリンを2′−
〇−メチルウリジンの製造法と同様な方法で、例えば3
’、5’水酸基を1.1,3.3.テトライソグロピル
シリル基で保護し、2′水酸基をメチル化し、6位のぞ
ロル基をアンモニアで処理することにょジアミノ基に置
換し、3’+5’水酸基が保護された2′−O−メチル
アデノシンを製造することができる。
Preparation of 2'-0-methyl-N6 protected-a≠nosine 6-chloro-9-(β-D-ly?72nosyl) f-phosphorus
For example, 3
', 5' hydroxyl group 1.1, 3.3. 2'-O- with tetraisoglopylsilyl group protected, 2' hydroxyl group methylated, 6-position diol group replaced with diamino group by treatment with ammonia, 3'+5' hydroxyl group protected Methyladenosine can be produced.

次いでこれをベンゾイル基のよりなアシル基で6位のア
ミノ基を保護し、3’、5’ −0−LL3+3+テト
ライングロビルジシリル基を7.化n−ブチルアンモニ
ウムで脱保護し、2’−0−メチル−N保護アデノシン
を製造することができる。尚、2’−0−メチル−N保
護アデノシンが不純物を含む場合はシリカダルクロマト
グラフィーを行ない精製することができる。
Next, the amino group at the 6-position was protected with a more acyl group of the benzoyl group, and the 3', 5' -0-LL3+3+tetrainglobil disilyl group was converted to 7. By deprotecting with n-butylammonium chloride, 2'-0-methyl-N-protected adenosine can be produced. If the 2'-0-methyl-N-protected adenosine contains impurities, it can be purified by silica dal chromatography.

グアノシンの2位のアミノ基を例えばインブチリル基の
ようなアシル基で保護し、5′水酸基を2′−〇−メチ
ルウリジンの一般的製法の項で記載したような保護基で
保護し、塩化第一錫とジアゾメタンによシ2’−0−メ
チル化し、これを3′−〇−メチル化体とシリカダルク
ロマトグラフィーによシ分離後5′−〇−保護基を除去
することによシ2′−O−メチル−N保護グアノシンを
製造することがテキる。尚2′−O−メチル−N保護グ
アノシンが不純物を含む場合はシリカグルクロマトグラ
フィ−を行ない精製することができる。
The amino group at the 2-position of guanosine is protected with an acyl group such as imbutyryl group, the 5' hydroxyl group is protected with a protecting group as described in the section of the general method for producing 2'-0-methyluridine, and 2'-0-methylation with tin and diazomethane, separation of the 3'-0-methylated product by silica dal chromatography, and removal of the 5'-0-protecting group. It is possible to produce '-O-methyl-N protected guanosine. If the 2'-O-methyl-N-protected guanosine contains impurities, it can be purified by silica gluchromatography.

例えば、目的蛋白質のアミノ酸配列に対応するメツセン
ジャーRNAの部分構造のような配列を有する2′−〇
−メチルオリプヌクレオチドの製造方法は、デオキシ及
びリゲオリコ9ヌクレオチドにおける鎖長延長方法とし
て、リン酸トリエステル法及び亜リン酸トリエステル法
(以下ホスファイト法)が現在知られているが、これら
のいずれの方法を用いても良い。従りてそれぞれの方法
の原料になシ得る保護されたヌクレオチドは前述の2′
−O−メチル−N保護ヌクレオチドの5′水酸基を例え
ばジメトキシトリチル基或いはモノメトキシトリチル基
のような保護基で保護し、3′水酸基をリン酸化するこ
とによシ製造できる。リン酸化剤としては三価のリンで
あるオルトクロロフェニルフォスフオシドリアゾリド等
を用いてリン酸化すればリン酸トリエステル法の原料を
供することができ、又、三価のリンを有するN−ジイソ
グロビルアミノーメトキシークロロホスフィン等を用い
てリン酸化すればホスファイト法の原料を供することが
できる。又、予め定められた配列中で、3′末端に位置
するヌクレオチドは、5’−0−保護−N ・保護−2
′−〇−メチルヌクレオチドをコハク酸等のジカル?ン
酸基を介してシリカグル、ポリスチレン、又はポーラス
ガラスのような有機溶剤に不溶性の樹脂に結合させてお
けば固相担体上で縮合反応を行なうことができる。縮合
において、リン酸) IJエステル法ではアレーンスリ
ホニルニトロトリアゾールなどの縮合剤を用いて鎖長を
延長できるし、又、ホスファイト法ではテトラゾールを
用いてリン原子を活性化し鎖長を延長できる。その際予
め定められた配列に必要な塩基を順次縮合することによ
シ任意の配列をもつ2′−〇−メチルオリゴヌクレオチ
ドを製造することができる。
For example, a method for producing 2'-〇-methyl oligonucleotide having a sequence similar to the partial structure of Metsenger RNA that corresponds to the amino acid sequence of the target protein uses phosphate The triester method and the phosphite triester method (hereinafter referred to as the phosphite method) are currently known, and any of these methods may be used. Therefore, the protected nucleotides that can be used as raw materials for each method are the aforementioned 2'
It can be produced by protecting the 5' hydroxyl group of an -O-methyl-N protected nucleotide with a protecting group such as dimethoxytrityl group or monomethoxytrityl group, and phosphorylating the 3' hydroxyl group. If phosphorylation is performed using trivalent phosphorus, such as orthochlorophenyl phosphoside diazolide, as a phosphorylating agent, a raw material for the phosphoric acid triester process can be provided. Phosphorylation using isoglobylaminomethoxychlorophosphine or the like can provide a raw material for the phosphite method. In addition, in the predetermined sequence, the nucleotide located at the 3' end is 5'-0-protected-N, protected-2
′-〇-Methyl nucleotide with a radical such as succinic acid? If it is bonded to a resin insoluble in organic solvents such as silica glue, polystyrene, or porous glass via an acid group, the condensation reaction can be carried out on a solid support. In the condensation process, the chain length can be extended by using a condensing agent such as arenesulfonylnitrotriazole in the IJ ester method, and by activating the phosphorus atom using tetrazole in the phosphite method. . In this case, a 2'-0-methyl oligonucleotide having an arbitrary sequence can be produced by sequentially condensing the necessary bases to a predetermined sequence.

鎖長延長反応の終了し九固相担体上の完全に保護され&
2’−0−メチルオリゴヌクレオチドは、アンモニアで
処理することによ、9Nアシル基及びリン酸の脱保護と
樹脂からの切シはすしを同時に行なうことができる。又
、リン酸トリエステル法によシ合成した場合は、アンモ
ニアで処理する前に2−ピリジンアルドキシム・テトラ
メチルグアニジンで処理しておけば脱保護の収率は向上
する。
The chain lengthening reaction is completed and fully protected on a solid phase support.
By treating the 2'-0-methyl oligonucleotide with ammonia, the 9N acyl group and phosphoric acid can be deprotected and the 2'-0-methyl oligonucleotide can be cut from the resin at the same time. Furthermore, in the case of synthesis by the phosphotriester method, the yield of deprotection can be improved by treating with 2-pyridine aldoxime/tetramethylguanidine before treatment with ammonia.

一方ホスファイト法で合成した場合はその必要はない。On the other hand, this is not necessary when synthesized by the phosphite method.

以上のような方法で樹脂よシ切シ出された5′−〇−ジ
メトキシトリチルー2′−〇−メチルオリゴヌクレオチ
ド(若しくは5’−0−)リチル誘導体−2′−〇−メ
チルオリゴヌクレオチド)は逆相シリカダルを用いたカ
ラムクロマトグラフィーにょシ5′−〇にジメトキシト
リチル基(若しくは5’−0−トリチル誘導体)を持た
ない副生成物と分離することができる。
5'-〇-dimethoxytrityl-2'-〇-methyl oligonucleotide (or 5'-0-lythyl derivative-2'-〇-methyl oligonucleotide) excised from the resin by the above method can be separated from by-products that do not have a dimethoxytrityl group (or 5'-0-trityl derivative) in 5'-0 by column chromatography using reversed-phase silica gel.

このように分離された5′−〇−ジメトキシトリチルー
2′−〇−メチルオリゴヌクレオチド(若しくi!5’
−0−トリチル誘導体オリゴヌクレオチド)は酸性条件
下で5’−〇−ジメトキシトリチル基(若しくは5’−
0−トリチル誘導体)を除去し、陰イオン交換樹脂又は
逆相シリカダルを用いたカラムクロマトグラフィーや尿
素又はホルムアミド等で変性させたポリアクリルアミド
ゲル電気泳動によシ、目的とする完全に保護基の除去さ
れた2’ −0−メチルオリゴヌクレオチドを単離精製
することができる。
The 5'-〇-dimethoxytrityl-2'-〇-methyl oligonucleotide (or i!5'
-0-trityl derivative oligonucleotide) under acidic conditions.
0-trityl derivative) and completely remove the protecting group by column chromatography using anion exchange resin or reversed-phase silica gel or electrophoresis on polyacrylamide gel denatured with urea or formamide, etc. The resulting 2'-0-methyl oligonucleotide can be isolated and purified.

実施例 2′−〇−メチルウリジンは反応式lに示したルートに
よシ製造した。
Example 2'-0-Methyluridine was prepared by the route shown in Reaction Scheme 1.

ウリジン10.9をピリジン801ntに溶解し水冷下
で攪拌しながら、これに1.3−ジクロル−1,1゜3
.3−テトライソグロビルジシロキサン14−(1,1
当量)を加え、室温まで加温し140分間攪拌を続けた
。次にこれを氷冷し水40−を加えて反応を中止せしめ
た後、クロロホルム−水で分液し、クロロホルム層を水
で洗浄した。クロロホルム層をとシ溶媒留去し、得られ
た混合物をシリカfyC−200,5ooIを詰めたカ
ラムクロマトグラフィーを行ない2.5%メタノール−
97,5%クロロホルムで溶出される両分を集め、溶媒
を留去し純粋な1bを18.71!、93.6%の収率
で得た。
10.9 of uridine was dissolved in 801 nt of pyridine, and while stirring under water cooling, 1,3-dichloro-1,1°3 was added to the solution.
.. 3-tetraisoglobildisiloxane 14-(1,1
equivalent amount) was added, the mixture was warmed to room temperature, and stirring was continued for 140 minutes. Next, this was cooled on ice and 40% of water was added to stop the reaction, and the mixture was separated into layers with chloroform and water, and the chloroform layer was washed with water. The chloroform layer was removed and the solvent was distilled off, and the resulting mixture was subjected to column chromatography packed with silica fyC-200,5ooI and 2.5% methanol-
Both fractions eluted with 97.5% chloroform were collected, the solvent was distilled off, and pure 1b was obtained at 18.71%! , with a yield of 93.6%.

3’、5’−0−テトライソグロビルシシリルーウリジ
ン(Ib)UVスペクトル(メタノール):λmax2
61 nm+λmin229nm(塩基性):λmax
 261 n1llTλmin242nm’H−NMR
:  δppm 8.82(s+、l、3−H)7.7
0(d、l 、6−H,J=8.06Hz)5.73 
(d 、 2 、5−H,1’−H,J=6.84Hz
 )4.15 (m + 512’−Hl 3’−HI
4’−H15’−H)3.14(br、1.2’−0H
) 1.1  (m 、 28 、 TIPDS基)化合物
1b15JFをジメチルアセトアミド150dに溶解し
トリエチルアミン5.55d(1,3当量)をこれに加
えた後水冷し、塩化ベンゾイル3.94+d(1,1当
量)を滴下しながら加え室温に戻した後180分間攪拌
した。次に反応混合物を濃縮後酢酸エチル−水で分液し
、酢酸エチル層を水洗後無水硫酸ナトリウムで乾燥させ
濃縮乾固した。残渣はシリカゲルC−300,350g
を詰めたカラムクロマトグラフィーによシ分離精製し0
.2.1 酢酸エチル−99,8%クロロホルム混合液
で溶出される純粋画分を集め溶媒を留去し化合物1cを
11.6.F 、 63.996の収率で得た。
3',5'-0-tetraisoglovirsicilyuridine (Ib) UV spectrum (methanol): λmax2
61 nm+λmin229nm (basic): λmax
261 n1llTλmin242nm'H-NMR
: δppm 8.82 (s+, l, 3-H) 7.7
0(d,l,6-H,J=8.06Hz)5.73
(d, 2, 5-H, 1'-H, J=6.84Hz
)4.15 (m + 512'-Hl 3'-HI
4'-H15'-H) 3.14(br, 1.2'-0H
) 1.1 (m, 28, TIPDS group) Compound 1b15JF was dissolved in 150 d of dimethylacetamide, 5.55 d (1,3 equivalents) of triethylamine was added thereto, cooled with water, and benzoyl chloride 3.94+d (1,1 equivalents) was dissolved. ) was added dropwise to the mixture, and after returning to room temperature, the mixture was stirred for 180 minutes. Next, the reaction mixture was concentrated and separated into layers with ethyl acetate and water, and the ethyl acetate layer was washed with water, dried over anhydrous sodium sulfate, and concentrated to dryness. The residue is silica gel C-300, 350g
Separated and purified by column chromatography packed with 0
.. 2.1 Pure fractions eluted with ethyl acetate-99.8% chloroform mixture were collected, the solvent was distilled off, and compound 1c was extracted from 11.6. F, obtained in a yield of 63.996.

C UVスペクトル(メタノ−#):λmax252nm、
λmin221nm(塩基性):λmax252 nm
 、λmin223nm1H−NMR(CDC6,):
δppm 7.94 (d 、 1.6−H,J=6.
35Hz )7.84−7.49(m、5.N −ベン
ゾ(ル基)5.81(d、2.5−H,1’−H,J=
8.3Hz)4.18(m、 5 +2’−Hl3’−
H,4’−H,5’−H)2.85(br 、1.2’
−0H) 1.1 (m 、 28 、 TIPDS基)化合物I
 e 7.3511をベンゼン70dに溶解しAg2O
8,26g(2,g当量)を加えた後数十分間超音波を
かけ、CH3119,36m(25轟量)を加え40℃
で一晩攪拌した。反応混合物を濾過後濾液を濃縮し、ク
ロロホルム−水で分液しクロロホルム層を水洗し、無水
硫酸す) IJウムで乾燥後溶媒を留去し、得られた残
渣をシリカy/I/c−200゜20ONを詰めたカラ
ムクロマトグラフィーを行ない0.5チメタノール−9
9,51%クロロホルムで溶出される純粋画分を集め、
溶媒を留去し、化合物1dを6.34.9(84,3チ
の収率で)得た。
C UV spectrum (methano-#): λmax 252 nm,
λmin221nm (basic): λmax252nm
, λmin223nm 1H-NMR (CDC6,):
δppm 7.94 (d, 1.6-H, J=6.
35Hz) 7.84-7.49 (m, 5.N-benzo(ru group) 5.81 (d, 2.5-H, 1'-H, J=
8.3Hz) 4.18(m, 5 +2'-Hl3'-
H, 4'-H, 5'-H) 2.85 (br, 1.2'
-0H) 1.1 (m, 28, TIPDS group) Compound I
e 7.3511 was dissolved in benzene 70d and Ag2O
After adding 8.26g (2.g equivalent), ultrasonication was applied for several tens of minutes, and CH3119.36m (25g amount) was added and heated at 40°C.
The mixture was stirred overnight. After filtering the reaction mixture, the filtrate was concentrated, separated with chloroform and water, the chloroform layer was washed with water, and anhydrous sulfuric acid was added. After drying over IJum, the solvent was distilled off, and the resulting residue was purified with silica y/I/c- Perform column chromatography packed with 200° 20ON and 0.5 timethanol-9.
Collect the pure fractions eluted with 9.51% chloroform,
The solvent was distilled off to obtain 6.34.9 (yield: 84.3) of compound 1d.

d UVスn7)ル(メタノール):λmax252nm、
λmin221nm(塩基性):λmax252nme
λmin225nm’ H−NMR(CDC13) :
δppm8.03(d、1t6−H,J=8.3Hz)
7.99−7.50(m+5 、N5−benzoyl
基)5.80 (d 、 2 、5−H、l’−H,J
=7.08Hz)4.05 (m 、 5 、2’−H
,3’−H,4’−H,5’−H)3.60 (s 1
1.2’−0CHs )1.1  (m、28.TIP
DS基)次にこれをジオキサン90mに溶解し、これに
濃アンモニア水を11−加え室温で4時間30分攪拌し
た。この反応混合物を濃縮後、クロロホルム−水で分液
し、クロロホルム層を水、次いで0.5%炭酸水素ナト
リウム水溶液で洗浄後、無水硫酸す) IJウムで乾燥
し溶媒を留去した。得られた残渣をシリカゲルC−20
0,150gを詰めたカラムクロマドグ2フイーによシ
分離精製し、lチメタノール−99チクロロホルムで溶
出される純粋画分を集め溶媒を留去し、化合物Ieを4
.98.9゜95.2%の収率で得た。
d UV light (methanol): λmax 252 nm,
λmin221nm (basic): λmax252nme
λmin225nm' H-NMR (CDC13):
δppm8.03 (d, 1t6-H, J=8.3Hz)
7.99-7.50 (m+5, N5-benzoyl
group) 5.80 (d, 2, 5-H, l'-H, J
=7.08Hz)4.05 (m, 5, 2'-H
, 3'-H, 4'-H, 5'-H) 3.60 (s 1
1.2'-0CHs ) 1.1 (m, 28.TIP
DS group) Next, this was dissolved in 90 ml of dioxane, and concentrated aqueous ammonia was added thereto, followed by stirring at room temperature for 4 hours and 30 minutes. The reaction mixture was concentrated, separated into layers with chloroform and water, and the chloroform layer was washed with water and then with a 0.5% aqueous sodium bicarbonate solution, dried over anhydrous sulfuric acid, and the solvent was distilled off. The obtained residue was treated with silica gel C-20.
The pure fraction eluted with 1-thimethanol-99-thichloroform was collected and the solvent was distilled off, and compound Ie
.. It was obtained in a yield of 98.9° and 95.2%.

s σV吸収スイクトル(メタノール):λmax261n
m+λmin222nm(塩基性):λmax260n
m+λmin242nm化合物162.89gをジオキ
サン30ゴに溶解し、これに1規定塩酸30−を加え、
室温で3時間30分攪拌後、 Dowex lX2(b
icarbonate form)によシ中和した。こ
れを濾過し、樹脂はメタノール−水(1:10)で洗浄
し、その洗液と濾液を合わせて溶媒留去した。得られた
残渣をメタノール−水(1:10)3001ntに溶か
し、クロロホルムで洗浄し、クロロホルム層は水で逆抽
出し、水層は合わせて濃縮乾固後メタノールを加え溶媒
を留去した。得られた残渣はメタノール20t/−酢酸
エチル80m1を加え加熱しながら溶解し、熱時濾通抜
濾液を放冷して2′−〇−メチルウリジン(I r)の
針状結晶1.31.!i’を収率87.9%で得た。
s σV absorption quictor (methanol): λmax261n
m+λmin222nm (basic):λmax260n
162.89 g of m+λmin 242 nm compound was dissolved in 30 g of dioxane, and 1 N hydrochloric acid was added to this,
After stirring at room temperature for 3 hours and 30 minutes, Dowex lX2 (b
icarbonate form). This was filtered, the resin was washed with methanol-water (1:10), and the washing liquid and filtrate were combined and the solvent was distilled off. The obtained residue was dissolved in 3001 nt of methanol-water (1:10), washed with chloroform, the chloroform layer was back-extracted with water, the aqueous layers were combined and concentrated to dryness, then methanol was added and the solvent was distilled off. The obtained residue was dissolved while heating by adding 20 t of methanol/80 ml of ethyl acetate, filtered out while hot, and the filtrate was allowed to cool to give acicular crystals of 2'-0-methyluridine (Ir). ! i' was obtained in a yield of 87.9%.

If UVスペクトル(メタノール):λmax261nm、
λmin230nm(塩基性):λmax260nms
λml n 242nm元素分析値 測定値二C,46
,59:H,5,39:N、11.11理論値(C,o
H14N206):C,46,51:H,5,46:N
、 10.84Massスペクトル m/e  258
(M”)  、147(す?−ス)融点 156〜15
9℃ 1H−NMR(DMSO−d6 )δppm 11.3
6 (a 、 1 、N’−H)7.93(d、1.6
−H,J=8.3Hz)5.86 (d 、 l 、 
1’−H,J=5.12Hz )5.66(d、1.5
−H,J−8,06Hz)4.12(m、1.2’−H
) 3.80(m、4 *3’−H+4’−H+5’−H)
3.36 (s + m 、2’−OCHs )尚、3
’15’シリル基の除去方法としては、2’−0−メチ
ル−N6ペンゾイルアデノシンの製造の際に用いた条件
、即ち7ツ化テトラ−n−2チルアンモニウムを用いる
方法を応用することもできる。
If UV spectrum (methanol): λmax 261 nm,
λmin230nm (basic): λmax260nms
λml n 242nm elemental analysis value Measured value 2C, 46
, 59:H, 5, 39:N, 11.11 theoretical value (C, o
H14N206):C,46,51:H,5,46:N
, 10.84Mass spectrum m/e 258
(M”), 147 (S?-S) melting point 156-15
9°C 1H-NMR (DMSO-d6) δppm 11.3
6 (a, 1, N'-H) 7.93 (d, 1.6
-H, J=8.3Hz) 5.86 (d, l,
1'-H, J=5.12Hz)5.66(d,1.5
-H,J-8,06Hz)4.12(m,1.2'-H
) 3.80 (m, 4 *3'-H+4'-H+5'-H)
3.36 (s + m, 2'-OCHs), 3
As a method for removing the '15' silyl group, the conditions used in the production of 2'-0-methyl-N6 penzoyladenosine, that is, the method using tetra-n-2 thylammonium heptadide, can also be applied. .

反応式 1 %式% BT、=ベンゾイル基 2′−O−メチル−N4−ベンゾイルシチジンの製造2
′−O−メチル−N4−ベンゾイルシチジンは反応式2
−に示し次ルートで製造した文献(T、5asalci
+Y、Mizuno + Chem、 Pharm、 
Bull r 15巻、894頁、1967年)に従っ
てN−4位を選択的にベンゾイル化したシチジンを原料
に用い、2’−0−メチルウリジンの製造法に従って(
但し、N−3位のベンゾイル化は省略する)2’−0−
メチル−N4−ベンゾイルシチジンIleを製造し念。
Reaction formula 1% Formula% BT, = benzoyl group 2'-O-methyl-N4-benzoylcytidine production 2
'-O-methyl-N4-benzoylcytidine has the reaction formula 2
- The literature (T, 5asalci) produced by the following route shown in
+Y, Mizuno + Chem, Pharm,
Bull r vol. 15, p. 894, 1967) using cytidine selectively benzoylated at the N-4 position as a raw material, and according to the method for producing 2'-0-methyluridine (
However, benzoylation at the N-3 position is omitted)2'-0-
Methyl-N4-benzoylcytidine Ile was prepared.

1e αスペクトル (メタノール):λmax 259 nm + 303
 nm *λmin284nm (塩基性):λmax 317 nm +λmin26
0nm(酸 性):λmax 257 nm + 31
7 nm *λmin282nm 融点 178〜180℃ Ma g IIス−I’クトル  361(M+)、2
16(B+2)1H−NMR(DMSO−d6) :δ
ppm 11.22(s、1.N’−H)8.55 (
d 、 1 、6−H,J=7.57Hz )7.98
〜7.47 (m 、 5 、 N’−ベンゾイル基)
5.89 (d 、 1 、1’−H,J=2.2Hz
 )3.48 (s 、 3 、2” 0CH5)Ue
    (3’、5’−0−TIPDS−N’−ペンシ
イに’/fジン)UV吸収スペクトル (メタノール):λmax 259 nm * 303
 nm +λmin284nm (塩基性):λmax 317 nm +λmin26
0nm(酸 性):λmax258nm、315nm 
Iλmin282nm ffd  (2’−0−メf+3’+5’−0−TIP
DS−N’−ぺyシイhシfジy)石吸収スペクトル (メタノール):λwax 259 nm 1303 
nm 。
1e α spectrum (methanol): λmax 259 nm + 303
nm *λmin284nm (basic): λmax 317 nm +λmin26
0nm (acidic): λmax 257 nm + 31
7 nm *λmin282nm Melting point 178-180°C Mag II Su-I'cutor 361 (M+), 2
16(B+2)1H-NMR (DMSO-d6): δ
ppm 11.22 (s, 1.N'-H) 8.55 (
d, 1, 6-H, J=7.57Hz) 7.98
~7.47 (m, 5, N'-benzoyl group)
5.89 (d, 1, 1'-H, J=2.2Hz
)3.48 (s, 3, 2” 0CH5)Ue
(3',5'-0-TIPDS-N'-Pencyi'/fgin) UV absorption spectrum (methanol): λmax 259 nm * 303
nm +λmin284nm (basic): λmax 317 nm +λmin26
0nm (acidic): λmax 258nm, 315nm
Iλmin282nm ffd (2'-0-mef+3'+5'-0-TIP
DS-N'-PyCy) stone absorption spectrum (methanol): λwax 259 nm 1303
nm.

λmin284nm (塩基性):λmax 317 nm aλmin26
0nm(酸 性):λmax258nm、31ぎnm 
λmin284nm (basic): λmax 317 nm aλmin26
0 nm (acidic): λmax 258 nm, 31 nm
.

λmin282nm ’H−NMR(CDC1,) : δppm8.40 (d 、 1 、6−H,J=7.
33 )7.88−7.50 (m、5 、N’−ベン
ゾイル基)4.25−3.79 (m、 5 、2’−
H,3’、−H,4’−H,5’ −H)3.74(s
 、3.2’−0−CH3)1.1  (m 、 28
 、 TIPDS基)反応式 2 2′−O−メチル−N6−ペンゾイルアデノシンは反応
式3に示し九ルートで製造し次。
λmin282nm'H-NMR (CDC1,): δppm8.40 (d, 1, 6-H, J=7.
33) 7.88-7.50 (m, 5, N'-benzoyl group) 4.25-3.79 (m, 5, 2'-
H, 3', -H, 4'-H, 5' -H) 3.74 (s
, 3.2'-0-CH3) 1.1 (m, 28
, TIPDS group) Reaction formula 2 2'-O-methyl-N6-penzoyladenosine was prepared by nine routes shown in Reaction formula 3.

6−クロロ−9−(β−D−IJ&7ラノシル)プリン
6.211を用い、常法(2’−0−メチルウリジンの
製造法に準じて)に従い、3’+−5’ −0−テトラ
イソプロビルジシリル化体(化合物m−b>を9.45
g、82.4%の収率で得九。
Using 6-chloro-9-(β-D-IJ&7lanosyl)purine 6.211, 3'+-5'-0-tetra Isoprobyl disilylated product (compound m-b>9.45
g, with a yield of 82.4%.

b ■吸収スペクトル(メタノール)(酸性、塩基性、中性
とも):λmax 264 nm +λmin226n
m1H−NMR(CDCl2) :δppm 8.70
(s 、 1.8−H)8.32(s 、1 .2−H
) 6.07 (s 、 1  、1’−H)5.02(m
、1.2’−H) 4.61 (m 、 1 、3’−H)4.11  (
m、2.4’−H) 3.26 (m 、 1 、5’−H)1.12(龜、
1.2’−0H) 1.1  (m、28 、TIPDSi基)次にこの化
合物(I[Ib) 9.42 li、及びAg2゜20
.7g(5当量)にCH3I 100−を加え40℃で
50分間攪拌し、濾過後F液を濃縮乾固した。
b ■ Absorption spectrum (methanol) (acidic, basic, neutral): λmax 264 nm + λmin 226n
m1H-NMR (CDCl2): δppm 8.70
(s, 1.8-H)8.32(s, 1.2-H
) 6.07 (s, 1, 1'-H) 5.02 (m
, 1.2'-H) 4.61 (m, 1, 3'-H) 4.11 (
m, 2.4'-H) 3.26 (m, 1, 5'-H) 1.12 (pin,
1.2'-0H) 1.1 (m, 28, TIPDSi group) Next, this compound (I[Ib) 9.42 li, and Ag2゜20
.. 100- of CH3I was added to 7 g (5 equivalents), stirred at 40°C for 50 minutes, filtered, and then concentrated to dryness.

得られた残渣をクロロホルムに溶解し、0.5%チオ硫
酸ナトリウム水溶液、次いで水で洗浄し、クロロホルム
層は無水硫酸ナトリウムで乾燥後濃縮して、シリカゲル
C−200,400,9を詰め九カラムクロマトグラフ
ィーをにょる分離精製を行ない1チメタノール−99チ
クロロホルムで溶出される純粋画分を集め溶媒を留去し
、化合物mcを6.41!!(66,1チ)の収率で得
た。
The obtained residue was dissolved in chloroform, washed with a 0.5% aqueous sodium thiosulfate solution and then with water, and the chloroform layer was dried over anhydrous sodium sulfate, concentrated, and packed with silica gel C-200,400,9 into nine columns. Separation and purification was performed using chromatography, and the pure fraction eluted with 1-thimethanol-99-thichloroform was collected, the solvent was distilled off, and the compound mc was 6.41! ! Obtained in a yield of (66.1 h).

αスイクトル(メタノール)(中性、塩基性、酸性とも
):λmax 264 nm +λmin230nm1
H−NMR(CDC23):δppm 8.73 (s
 、 1 、8−H)8.45(s、1.2−H) 6.10 (s 、 1 、1’−H)4.70 (m
 、 1 、2’−H)4.09 (rn+4+3’−
H,4’−H。
α sictor (methanol) (neutral, basic, acidic): λmax 264 nm + λmin 230 nm1
H-NMR (CDC23): δppm 8.73 (s
, 1, 8-H) 8.45 (s, 1.2-H) 6.10 (s, 1, 1'-H) 4.70 (m
, 1, 2'-H) 4.09 (rn+4+3'-
H, 4'-H.

5′−H) 3.72 (s 、 3 、2’0− OH5)1.1
  (m 、 28 、TIPDS基)次にこの化合物
(Illc ) 4.451をジクロルメタン30ゴに
溶かし、封管に入れ冷却化液体アンモニア301nlを
加え密封し、室温で24時間攪拌した。次いで減圧下ア
ンモニアを留去した反応液にジクロルメタン200dを
加えて溶解し、希炭酸水素ナトリウム水溶液、次いで水
で洗浄後ジクロルメタン層は無水硫酸す) IJウムで
乾燥し溶媒を留去し念残渣をシリカゲルC−200,1
20Fを詰めたカラムクロマトグラフィーによυ分離精
製し、1.5%メタノール−98,5%クロロホルムで
溶出される純粋画分を集め溶媒を留去した。得られ良化
合物II[dは少量のメタノールより再結晶化し最終的
に2.67g、66.0%の収率で得た。
5'-H) 3.72 (s, 3, 2'0-OH5) 1.1
(m, 28, TIPDS group) Next, this compound (Illc) 4.451 was dissolved in 30 g of dichloromethane, placed in a sealed tube, added with 301 nl of cooled liquid ammonia, sealed, and stirred at room temperature for 24 hours. Next, 200 d of dichloromethane was added and dissolved in the reaction solution from which ammonia had been distilled off under reduced pressure. After washing with a dilute aqueous sodium bicarbonate solution and then with water, the dichloromethane layer was dried with anhydrous sulfuric acid. The solvent was distilled off to remove a residual residue. Silica gel C-200,1
The product was separated and purified by column chromatography packed with 20F, and the pure fraction eluted with 1.5% methanol-98.5% chloroform was collected and the solvent was distilled off. The obtained good compound II[d was recrystallized from a small amount of methanol to finally obtain 2.67 g with a yield of 66.0%.

11d 匠吸収スペクトル(M・OH): (中性、塩基性):λmax 259 nm 、λmi
n233nm(酸 性):λmax 257 nm +
λmin 234 nmMassスペクトルm/e  
523 (M+)、480(M−43)’H−NMR(
CDC/=、) :δppm8.33 (s 、 1 
、8−H)8.13(s、1.2−H) 6.03 (s 、 1 、1’−H)5.71(s、
2,6−NH2) 4.70 (m 、 1 、2’−H)4.11 (m
、4.3’−H,4’−H。
11d Takumi absorption spectrum (M・OH): (neutral, basic): λmax 259 nm, λmi
n233nm (acidic): λmax 257 nm +
λmin 234 nmMass spectrum m/e
523 (M+), 480 (M-43)'H-NMR (
CDC/=, ): δppm8.33 (s, 1
, 8-H) 8.13 (s, 1.2-H) 6.03 (s, 1, 1'-H) 5.71 (s,
2,6-NH2) 4.70 (m, 1, 2'-H) 4.11 (m
, 4.3'-H, 4'-H.

5’−H) 3.72 (s 、 3.2’−OCH3)1.1  
(m、28.TIPDS基)次に化合物旧2Iをピリジ
ン2o−に溶解させ、氷冷し、これに塩化ベンゾイル0
.57m(1,3fi量)を加え、室温まで加温し、2
時間攪拌後、反応液を氷冷し水5rntを加え反応を停
止させた。これにクロロホルム150−を加え、飽和炭
酸水素ナトリウム水溶液で洗浄、次いで水で洗浄し、有
機層は無水硫酸ナトリウムで乾燥後溶媒を留去した・得
られた残渣はシリカゲルC−200,60gを詰め几カ
ラムクロマトグラフィーによ)分離精製し、1チメタノ
ール−99%クロロホルム混合溶媒で溶出された純粋画
分を集め濃縮乾固させ化合物11[eを1.11.9得
た。一方lieよ・シも先に溶出されるN6−ジベンゾ
イル体は別途集め溶媒を留去し、残渣をメタノール9−
に溶かし濃アンモニア水1−を加え室温で10分間反応
させた後溶媒を留去し几0得られた残渣をクロロホルム
3〇−に溶かし、飽和炭酸水素ナトリウム水溶液、次い
で水で洗浄後無水硫酸す一トリウムで乾燥し、濃縮乾固
し化合物1[[eを得几。収率は合わせて88.8%で
あった。
5'-H) 3.72 (s, 3.2'-OCH3) 1.1
(m, 28.TIPDS group) Next, compound old 2I was dissolved in pyridine 2o-, cooled on ice, and benzoyl chloride
.. Add 57m (1,3fi amount), warm to room temperature,
After stirring for an hour, the reaction solution was ice-cooled and 5rnt of water was added to stop the reaction. Chloroform 150- was added to this, washed with a saturated aqueous sodium bicarbonate solution, then washed with water, the organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off.The resulting residue was packed with 60 g of silica gel C-200. The pure fractions eluted with a mixed solvent of 1 timethanol and 99% chloroform were collected and concentrated to dryness to obtain 1.11.9 of Compound 11[e]. On the other hand, the N6-dibenzoyl compound eluted first was collected separately, the solvent was distilled off, and the residue was mixed with methanol 9-dibenzoyl.
Add concentrated aqueous ammonia (1-1) dissolved in 30-ml solution and react at room temperature for 10 minutes. The solvent was distilled off. The resulting residue was dissolved in 30-chloroform, washed with a saturated aqueous solution of sodium bicarbonate and then with water, and then diluted with anhydrous sulfuric acid. It was dried with monotrium and concentrated to dryness to obtain compound 1 [[e]. The total yield was 88.8%.

e 匠吸収スペクトル (メタノール):λmax279 nm 、λmin2
47nm(塩基性):λmax 307 nm *λm
in260nm化合物II[e 0.911にフッ化テ
トラーn−ブチルアンモニウム(TB、AF )の1m
ot/lテトラヒドロフラン溶液9ゴを加え室温で50
分間攪拌し友。
e Takumi absorption spectrum (methanol): λmax279 nm, λmin2
47nm (basic): λmax 307 nm *λm
1 m of tetra-n-butylammonium fluoride (TB, AF) in 260 nm compound II [e 0.911
Add 9 oz/l of tetrahydrofuran solution and stir at room temperature for 50 min.
Stir for a minute.

この反応液にピリジン−メタノール−水(容量比3:1
:1)20W1tを加え、この混合液を陽イオン交換樹
脂Dowex 50Wx2 (ピリジニウム型)3−の
入ったビーカーに加えた。これを濾過し、樹脂は前述の
ピリジン−メタノール−水で洗浄し、F液と合わせて濃
縮乾固した。得られた残渣はトルエン共沸後メタノール
を加えて溶かし、シリカダルC−200,7gを加えシ
リカ? /L/C−200,40,9を詰めたカラムに
充填し、クロマトグラフィーによシ分離精製し2.5チ
メタノール−97,5チクロロホルムで溶出される純粋
画分を集め濃縮乾固しI[rfを0.51.P、92.
7チの収率で得た。
Add pyridine-methanol-water (volume ratio 3:1) to this reaction solution.
:1) 20W1t was added, and this mixture was added to a beaker containing cation exchange resin Dowex 50Wx2 (pyridinium type) 3-. This was filtered, and the resin was washed with the above-mentioned pyridine-methanol-water, combined with Solution F, and concentrated to dryness. The obtained residue was azeotropically distilled with toluene, then methanol was added to dissolve it, and 7g of Silica Dull C-200 was added. /L/C-200,40,9 was packed in a column, separated and purified by chromatography, and the pure fraction eluted with 2.5-thimethanol-97,5-tichloroform was collected and concentrated to dryness. I[rf 0.51. P, 92.
It was obtained in a yield of 7.

■f W吸収スペクトル(メタノール):λmax279nm
+λmin247nm(塩基性):λmax310nm
+lλmin260nm反応式 3 If TfPDSiCt2−1.3−ジク四ルー1.1.3.
3−テトライソグロビルジシロキサン 2′−O−メチル−N2−イソブチリルグアノシンの製
造2′−O−メチル−N2−インプチリルグアノシyは
反応式4に示し念ルートで製造し次。常法に従って合放
し*5’−0−モノメトキシトリチル−N8−イソブチ
リルグアノシン69及び5nCt2 o、 38Il(
0,2当量)をジメチルホルムアミド480−に溶解さ
せ、これにジアゾメタンの1,2−ジメトキシエタン溶
液25−を0℃で約3時間かけて滴下しながら加え、更
に2時間攪拌後、濃アンモニア水0.5 tRtを加え
て溶媒を留去し九〇次に残渣にクロロホルムを加えて溶
かし水洗し、水層はクロロホルムで逆抽出し、クロロホ
ルム層は合わせて水洗後、無水硫酸す) IJウムで乾
燥し濃縮乾固した。
f W absorption spectrum (methanol): λmax 279 nm
+λmin247nm (basic):λmax310nm
+lλmin260nm Reaction formula 3 If TfPDSiCt2-1.3-diqtetraru 1.1.3.
Preparation of 3-tetraisoglobyldisiloxane 2'-O-Methyl-N2-isobutyrylguanosine 2'-O-Methyl-N2-isobutyrylguanosine y was prepared by the conceptual route shown in Reaction Scheme 4. According to a conventional method, combine *5'-0-monomethoxytrityl-N8-isobutyrylguanosine 69 and 5nCt2o, 38Il (
0.2 equivalent) was dissolved in dimethylformamide (480), and a solution of diazomethane in 1,2-dimethoxyethane (25) was added dropwise at 0°C over about 3 hours. After stirring for another 2 hours, concentrated aqueous ammonia was added. Add 0.5 tRt and distill off the solvent.Next, add chloroform to the residue, dissolve and wash with water.The aqueous layer is back-extracted with chloroform.The chloroform layers are combined and washed with water, then diluted with anhydrous sulfuric acid). It was dried and concentrated to dryness.

残渣はシリカダルC−200,200Fを詰めたカラム
クロマトグラフィーにより分離精製し、2チメタノール
−98チクロロホルムで溶出される2/ 、 3/メチ
ル体混合物■bを集め濃縮乾固しt0化合物■bは混合
物として3.31.9’、  54.0%の収率で得九
〇 1H−NMR(CDC1,) :699m  12.0
1(s、1.t−H)7.81(s、1.8−H) 4.78−3.61(m、6+2’−H,3’−H,4
’−H,5’−H,NLH)3.78 (s 、 3 
、0CH5、MMTr基)2.96 (a 、3 、2
’−0CH5)次にこの混合物IVb fJtKies
@Igal 60を用いるシリカゲルクロマトグラフィ
ーによシ分離精製しクロロホルム:アセトニトリル:メ
タノール=60=24:1(容積比)の混合溶媒で溶出
される2′−〇CI(、体の画分を集め、濃縮乾固した
。これに80チ酢酸40−を加え50℃で1時間攪拌し
た後溶媒を留去し、残渣をクロロホルム−水で分液し、
水層なりロロホルムで洗浄し几。水層は濃縮し、得られ
た残渣は水よシ再結晶化し、2’−0−CH。
The residue was separated and purified by column chromatography packed with Silica Dull C-200, 200F, and the 2/, 3/methyl compound mixture (b) eluted with 2-thimethanol-98 dichloroform was collected and concentrated to dryness to form t0 compound (b). was obtained as a mixture with a yield of 3.31.9' and 54.0%. 901H-NMR (CDC1,): 699m 12.0
1 (s, 1.t-H) 7.81 (s, 1.8-H) 4.78-3.61 (m, 6+2'-H, 3'-H, 4
'-H, 5'-H, NLH) 3.78 (s, 3
, 0CH5, MMTr group) 2.96 (a , 3 , 2
'-0CH5) Then this mixture IVb fJtKies
Separate and purify by silica gel chromatography using @Igal 60, collect fractions of 2'-○CI (2'-0CI) eluted with a mixed solvent of chloroform:acetonitrile:methanol=60=24:1 (volume ratio), It was concentrated to dryness. To this was added 40-80 thiacetic acid, and after stirring at 50°C for 1 hour, the solvent was distilled off, and the residue was separated between chloroform and water.
Wash the aqueous layer with loloform. The aqueous layer was concentrated, and the resulting residue was recrystallized from water to give 2'-0-CH.

体■cを0.49.9得た。Body ■c was obtained at 0.49.9.

F/c。F/c.

UV吸収スペクトル(H2O):λmax260nm+
λmii227nm(塩基性):λmax262nm+
λmin237nmMassスペクトk  m/e  
367(M )、437,507(M+ゼインチリル基
) ’H−NMR(DMSO−d6 ) :699m 8.
26(s 、 1.8−H)5.80 (d 、 1 
、1’−H)3.33 (s 、3.2’−0CH5)
反応式 4 lVa MMTr :モノメトキシトリチル基 2′−〇−メチル−リポオリゴヌクレオチドの製造2′
−〇−メチルウリジン(化合物If )、2′−〇−メ
fpv −N4−ベンゾイルシチジン(化合物Ice)
、2′−O−メチル−N6−ペンゾイルーアfノシン(
化合物II[f ’)及び2′−O−メチル−N2−イ
ンブチリルグアノシン(化合物fVe )を常法に従っ
て5′水酸基をジメトキシトリチル基(DMT )で保
護し、更に3′水酸基は文献(Nucleic Ac1
ds Re5erch %8巻、5461項、1980
年)記載の方法に従ってオルトクロロフェニルリン酸基
を導入した。文献(Nucleic Ac1ds R5
5archt 8巻、550−7−5517項、198
0年)に記載された方法に従って合成した5′−〇−ジ
メトキシトリチルー2′−〇−メチル−N2−イソプチ
リルグアノシ76μmolを結合し念1%クロスリンク
ポリスチレン樹脂501n9を用い、2′−〇−メチル
ヌクレオチドをU、C,C,A、U、U。
UV absorption spectrum (H2O): λmax 260nm+
λmii227nm (basic): λmax262nm+
λmin237nmMass spectrum k m/e
367 (M), 437,507 (M+zethyryl group) 'H-NMR (DMSO-d6): 699m 8.
26(s, 1.8-H)5.80(d, 1
, 1'-H) 3.33 (s, 3.2'-0CH5)
Reaction formula 4 lVa MMTr: Production of monomethoxytrityl group 2'-〇-methyl-lipo-oligonucleotide 2'
-〇-Methyluridine (Compound If), 2'-〇-Mefpv -N4-benzoylcytidine (Compound Ice)
, 2'-O-methyl-N6-penzoylua f-nosine (
The 5' hydroxyl group of Compound II [f') and 2'-O-methyl-N2-imbutyrylguanosine (compound fVe) was protected with a dimethoxytrityl group (DMT) according to a conventional method, and the 3' hydroxyl group was protected as described in the literature (Nucleic Ac1
ds Re5erch % Volume 8, Section 5461, 1980
An orthochlorophenyl phosphate group was introduced according to the method described in 2010). Literature (Nucleic Ac1ds R5
5archt Volume 8, Section 550-7-5517, 198
76 μmol of 5'-〇-dimethoxytrityl-2'-〇-methyl-N2-isoptyrylguanosynthesis synthesized according to the method described in -0-Methyl nucleotides U, C, C, A, U, U.

C,Aの頭に縮合し、鎖長延長を行なっ几。縮合の1サ
イクルは文献(Proa、 Natl、 Acacl、
 5ciUSA、81巻、5956項、1984@記載
の方法、即ち、表1に示し友通シで行なっ几。
It is condensed to the head of C and A to elongate the chain. One cycle of condensation is described in the literature (Proa, Natl, Acacl,
The method described in 5ciUSA, Vol. 81, Section 5956, 1984@, that is, the method shown in Table 1, was carried out at Tomotsushi.

即ち、5′−〇−ジメトキシトリチルー2’−0−メチ
ル−N!−イソプチリルグアノシ76μmolを結合t
、etsクロスリンクポリスチレン樹脂50■をグラス
フィルター付きの反応容器に入れジクロルメタン−メタ
ノール(容積比7:3)の混合液21ntで3回洗浄し
た。次に2%ベンゼンスルホン酸のジクロルメタン−メ
タノール(容積比7:3)溶液を2−加え1分間振盪し
た。反応後浴液は濾過によシ樹脂よシ除い念後樹脂はジ
クロルメタン−メタノール(容積比7:3)混合液2−
で洗浄した。更に前記のベンゼンスルホン酸溶液2−で
1分間反応させ次いで前記の混合液2ゴで2回、更にピ
リジン2−で3回洗浄した。次にピリジン0.3−を加
え、減圧下ピリジンを留去することによシ樹脂を乾燥し
念。次に5′−ジメトキシトリチル−2’−0−メチル
ウリジン−3′−オルトクロロフェニルリン酸のピリジ
ン溶液(201n910、3 d ’)を加え減圧下ピ
リジンを留去し几0次にメシチレンスルホニル−3−ニ
トロトリアソールのピリジン溶液(20■70.3 d
 )を加え40℃に加温し20分間振盪しt0反応液は
濾過によシ樹脂より除き、樹脂はピリジン2−で2回洗
浄した。次に、0.1Mジメチルアミノピリジン溶液1
.8−と無水酢酸0.2−とを加え3分間振盪し、未反
応の5′水酸基をアセチル基によジブロックした。反応
液は戸去しt後樹脂はピリジン2t11tで3回洗浄し
几。この一連の操作を繰多返しく但し、2′−〇−メチ
ル保護ヌクレオチドはそれぞれ必要な塩基を加える)鎖
長を延長した。
That is, 5'-0-dimethoxytrityl-2'-0-methyl-N! - Bind 76 μmol of isoptyrylguanosyl t
, ets cross-linked polystyrene resin (50 ml) was placed in a reaction vessel equipped with a glass filter and washed three times with 21 nt of a mixed solution of dichloromethane-methanol (volume ratio 7:3). Next, a solution of 2% benzenesulfonic acid in dichloromethane-methanol (volume ratio 7:3) was added twice and shaken for 1 minute. After the reaction, the bath liquid was filtered to remove the resin.
Washed with. Furthermore, it was reacted for 1 minute with the benzenesulfonic acid solution 2-, and then washed twice with the mixture 2- and then three times with pyridine 2-. Next, 0.3-g of pyridine was added, and the pyridine was distilled off under reduced pressure to dry the resin. Next, a pyridine solution of 5'-dimethoxytrityl-2'-0-methyluridine-3'-orthochlorophenyl phosphoric acid (201n910, 3d') was added and the pyridine was distilled off under reduced pressure. - Pyridine solution of nitrotriazole (20 x 70.3 d
) was added, heated to 40° C., and shaken for 20 minutes. The t0 reaction solution was removed from the resin by filtration, and the resin was washed twice with pyridine 2-. Next, 0.1M dimethylaminopyridine solution 1
.. 8- and 0.2-acetic anhydride were added and shaken for 3 minutes to diblock unreacted 5' hydroxyl groups with acetyl groups. After the reaction solution was removed, the resin was washed three times with 2 t and 11 t of pyridine. This series of operations was repeated until the length of the 2'-0-methyl-protected nucleotide (by adding the necessary bases) was extended.

各縮合反応の収率は脱ジメトキシトリチル化によって生
成し几ジメトキシトリタノールを過塩素酸−エタノール
中で発色させて500 nmにおける吸光度よシ定量し
た。
The yield of each condensation reaction was determined by the absorbance at 500 nm after the dimethoxytritanol produced by de-dimethoxytritylation was developed in perchloric acid-ethanol.

反応収率は以下のとおりであった(通算収率22チ)。The reaction yield was as follows (total yield: 22 cm).

5/N保@ (Am Cm Un UmAm Cm C
m UmGm ) 3’47837810294751
0495(チ)鎖長延長方向 ここで小文字のmは2′−〇−メチル基を表わし、各塩
基はオルトクロロフェニルリン酸を介し3′一51結合
で結ばれている。
5/N Ho @ (Am Cm Un UmAm Cm C
m UmGm ) 3'47837810294751
0495 (H) Direction of Chain Length Here, the lowercase letter m represents a 2'-0-methyl group, and each base is linked by a 3'-51 bond via orthochlorophenyl phosphoric acid.

次に合成終了後の樹脂なジオキサンで洗浄した後、2−
ピリジンアルドキシム・テトラメチルグアニジンの1M
ジオキサン溶液を0.5 m 、ジオキサン0.4−1
水0,1−を加え30℃で一晩振盪後、溶液’k濾過し
更に樹脂は50%ピリジン水2rRtで3回洗浄し友。
Next, after the synthesis was completed, the resin was washed with dioxane, and then 2-
1M of pyridine aldoxime tetramethylguanidine
Dioxane solution 0.5 m, dioxane 0.4-1
After adding 0.1% water and shaking overnight at 30°C, the solution was filtered, and the resin was washed three times with 50% pyridine water 2Rt.

炉液及び洗浄液を合わせて溶媒を留去した後、残渣をピ
リジン1−に溶解して封管に入れ、28チアンモニア水
10ゴを加え密栓し、60℃で5時間加熱し念。反応液
は濃縮乾固後逆相シリカダルCWaters社製Bon
dapack C18粒径35〜100μ)を詰めた、
直径0.7側、長さ12crRのカラムにアプライし、
移動相として5チから35%アセトニトリルの直線濃度
勾配をかけfl:、 50 mM酢酸−トリエチルアミ
ン緩衝液を用いたカラムクロマトグラフィーな行ない2
54 nm における吸光度で定量し5′ジメトキシト
リチルオリゴヌクレオチドは、分離され念。38番目の
フラクシロンをと少溶媒を留去した後80%酢酸水溶液
1−を加え室温で20分間放置し友。反応液は濃縮乾固
させ更に水と共沸させることによシ酢酸を除去しt0残
渣は水に溶かし酢酸エチルで洗浄後濃縮し、高速液体ク
ロマトグラフィーによシ更に精製し几0即ちs Nue
leosll 5CIBによシ1移動相として13チか
ら21チの直線濃度勾配をかけた0、1M酢酸−トリエ
チルアミン緩衝液(pH7,0)を用い1−7分の流速
で行ない溶出された。主ピークを分取し0.066 μ
mo1通算収率1.1チで2′−〇〇H3オリゴヌクレ
オチドを得友。得られ友オリがヌクレオチドは陰イオン
交換カラム(DEAE 2 SW )を用いた高速液体
クロマトグラフィーで分析を行なった結果、単一なピー
クを与え、はぼ純粋であることが確認できた。
After combining the furnace liquid and the washing liquid and distilling off the solvent, the residue was dissolved in 1-pyridine, placed in a sealed tube, added with 10 g of 28 thiammonium water, sealed tightly, and heated at 60° C. for 5 hours. The reaction solution was concentrated to dryness and then mixed with reverse phase silica dal CWaters Bon.
packed with dapack C18 particle size 35-100μ),
Apply to a column with a diameter of 0.7 and a length of 12crR,
Column chromatography was performed using a linear concentration gradient of 5% to 35% acetonitrile as the mobile phase and a 50 mM acetic acid-triethylamine buffer.
The 5' dimethoxytrityl oligonucleotide was separated as determined by absorbance at 54 nm. After distilling off the 38th fraxilon and the minor solvent, an 80% acetic acid aqueous solution was added and the mixture was left at room temperature for 20 minutes. The reaction solution was concentrated to dryness, and further azeotroped with water to remove cyanoacetic acid. The t0 residue was dissolved in water, washed with ethyl acetate, concentrated, and further purified by high performance liquid chromatography to give a solution of sNue.
Elution was carried out using 0.1M acetic acid-triethylamine buffer (pH 7.0) applied with a linear concentration gradient from 13 to 21 as the mobile phase using Leosll 5CIB at a flow rate of 1 to 7 minutes. Collect the main peak and 0.066μ
2'-〇〇H3 oligonucleotide was obtained with a total mo1 yield of 1.1. When the obtained nucleotide was analyzed by high performance liquid chromatography using an anion exchange column (DEAE 2 SW), it was confirmed that it gave a single peak and was highly pure.

塩基配列の確認は、2’ −0CH5オリゴヌクレオチ
ド0.050Dユニツトを〔γ−P ) ATPとポリ
ヌクレオチドキナーゼを用い5′末端を52Pでリン酸
化し、その試料を文献(Proc、 Natl+ Ac
ad、 5etUSA 70巻1209〜1213項、
1973年〕に記載されている方法に従って行なった。
To confirm the base sequence, the 5' end of a 2'-0CH5 oligonucleotide 0.050D unit was phosphorylated with 52P using [γ-P]ATP and polynucleotide kinase, and the sample was purified as described in the literature (Proc, Natl+Ac).
ad, 5etUSA Volume 70, Sections 1209-1213,
[1973].

そのオートラジオグラフィーより塩基配列が正しいこと
が証明され念。
The autoradiography confirmed that the base sequence was correct.

ハイブリッドの形成 2’ −OCR,オリゴヌクレオチド5’ Am Om
UmUmAm Cm Cm UmQm3’とそれに相補
的な配列のデオキシオリゴヌクレオチド5’ dCAG
GTAAGT3’とを等量ずつしかも濃度が波長260
tunで吸光度1.0になるように0.1M塩化ナトリ
ウムを含む10mMカコジル酸ナトリウム緩衝液は溶か
し60℃まで加温し、次に室温まで放冷し几。試料はセ
ルに入れ、分光光度計(BECKMANN社製、DU−
8B)を用い、温度を10℃から47℃まで2分間に1
℃の割合で温度を上昇させていき、各温度における波長
260nmでの吸光度を測定した。縦軸に吸光度、横軸
に温度をとると融解曲線が得られ、これよりTm(融解
温度)値は34.8℃と求められた。
Hybrid formation 2'-OCR, oligonucleotide 5' Am Om
UmUmAm Cm Cm UmQm3' and its complementary sequence deoxyoligonucleotide 5' dCAG
Equal amounts of GTAAGT3' and a concentration of wavelength 260
Dissolve 10 mM sodium cacodylate buffer containing 0.1 M sodium chloride so that the absorbance is 1.0 in the tun, warm it to 60°C, and then let it cool to room temperature. The sample was placed in a cell, and a spectrophotometer (manufactured by BECKMANN, DU-
8B), the temperature was increased from 10℃ to 47℃ every 2 minutes.
The temperature was increased at a rate of .degree. C., and the absorbance at a wavelength of 260 nm at each temperature was measured. A melting curve was obtained by plotting absorbance on the vertical axis and temperature on the horizontal axis, from which the Tm (melting temperature) value was determined to be 34.8°C.

次に同様な方法で、2’−〇−メチルオリゴヌクレオチ
ド5’ Am Cm Um Un Am Cm Cm 
Um Gm 3’ とそれに相補的な塩基配列であるリ
ゾオリゴヌクレオチド5’ CAGGUAAGU3’と
を用いて融解曲線を求め九〇但し温度は74℃1で上昇
させた0グラフよリTm値は56℃でありto一方fオ
キシオリゴヌクレオチド5’ d (ACUUACCU
G ) 3’とそれに相補的な塩基配列であるり?オリ
ゴヌクレオチド5’CAGGUAAGU3’とのTm値
は41℃であッft。
Next, in a similar manner, 2'-〇-methyl oligonucleotide 5' Am Cm Um Un Am Cm Cm
Determine the melting curve using Um Gm 3' and the lyso-oligonucleotide 5'CAGGUAAGU3', which is a base sequence complementary to it. Yes to f oxyoligonucleotide 5' d (ACUUACCU
G) 3' and its complementary base sequence? The Tm value with oligonucleotide 5'CAGGUAGU3' was 41°C.

特許用願人 味の素株式会社Patent applicant: Ajinomoto Co., Inc.

Claims (1)

【特許請求の範囲】[Claims] 2′−O−メチルウリジン、2′−O−メチル−N^4
−保護−シチジン、2′−O−メチル−N^6−保護−
アデノシン及び2′−O−メチル−N^2−保護−グア
ノシンより選ばれるリポシドを予め定められた配列順序
になるようにリポシドの5′−水酸基と3′−水酸基と
をリン酸を介して順次結合せしめ、保護基を脱離せしめ
ることを特徴とする2′−O−メチル化RNAの製造法
2'-O-methyluridine, 2'-O-methyl-N^4
-Protection-Cytidine, 2'-O-methyl-N^6-Protection-
A liposide selected from adenosine and 2'-O-methyl-N^2-protected-guanosine is sequentially attached to the 5'-hydroxyl group and 3'-hydroxyl group of the liposide via phosphoric acid in a predetermined arrangement order. A method for producing 2'-O-methylated RNA, which comprises binding and removing a protecting group.
JP60133182A 1985-06-19 1985-06-19 Production of 2'-0-methylated rna Pending JPS61291595A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60133182A JPS61291595A (en) 1985-06-19 1985-06-19 Production of 2'-0-methylated rna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60133182A JPS61291595A (en) 1985-06-19 1985-06-19 Production of 2'-0-methylated rna

Publications (1)

Publication Number Publication Date
JPS61291595A true JPS61291595A (en) 1986-12-22

Family

ID=15098601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60133182A Pending JPS61291595A (en) 1985-06-19 1985-06-19 Production of 2'-0-methylated rna

Country Status (1)

Country Link
JP (1) JPS61291595A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339842A2 (en) * 1988-04-27 1989-11-02 Isis Pharmaceuticals, Inc. Novel oligoribonucleotide derivatives and application thereof to antiviral agents
EP0739901A3 (en) * 1988-04-27 1996-11-13 Isis Pharmaceuticals, Inc. Novel oligoribonucleotide derivatives and application thereof to antiviral agents
WO1998055493A1 (en) * 1997-06-03 1998-12-10 Mori, Takahide Natural antitumor or antiviral substances and use of the same
US5962675A (en) * 1996-02-13 1999-10-05 Ribozyme Pharmaceuticals, Inc. Chemical syntheses of 2'-O-methoxy purine nucleosides

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339842A2 (en) * 1988-04-27 1989-11-02 Isis Pharmaceuticals, Inc. Novel oligoribonucleotide derivatives and application thereof to antiviral agents
EP0339842A3 (en) * 1988-04-27 1994-03-09 Isis Pharmaceuticals, Inc. Novel oligoribonucleotide derivatives and application thereof to antiviral agents
EP0739901A3 (en) * 1988-04-27 1996-11-13 Isis Pharmaceuticals, Inc. Novel oligoribonucleotide derivatives and application thereof to antiviral agents
US5962675A (en) * 1996-02-13 1999-10-05 Ribozyme Pharmaceuticals, Inc. Chemical syntheses of 2'-O-methoxy purine nucleosides
WO1998055493A1 (en) * 1997-06-03 1998-12-10 Mori, Takahide Natural antitumor or antiviral substances and use of the same
AU754370B2 (en) * 1997-06-03 2002-11-14 Itochu Techo-Chemical Inc. Natural antitumor or antiviral substances and use of the same
US6498149B1 (en) 1997-06-03 2002-12-24 Tsuneatsu Mori Natural antitumor or antiviral substances and use of the same

Similar Documents

Publication Publication Date Title
JP3015464B2 (en) Process for producing novel 2&#39;-0-alkyl nucleosides and phosphoramidites and use thereof
Jager et al. Oligonucleotide N-alkylphosphoramidates: synthesis and binding to polynucleotides
US8153365B2 (en) Oligonucleotide analogues
JP4236812B2 (en) Oligonucleotide analogues
US5914396A (en) 2&#39;-O-modified nucleosides and phosphoramidites
JP3081882B2 (en) Orthogonal removal of hydroxyl protecting groups by reduction and their use in the chemical synthesis of oligonucleotides
US20030134808A1 (en) Oligonucleotide analogues
EP0090789A1 (en) Chemical DNA synthesis
CN102596983A (en) Bridged artificial nucleoside and nucleotide
JPH06500107A (en) Oligos (α-arabinofuranosyl nucleotides) and their α-arabinofuranosyl precursors
JPH10195098A (en) New nucleotide analogue
Sheppard et al. Preparation of 2'-O-(. beta.-Cyanoethyl phosphoramidites) of 3'-Deoxycytidine and 3'-Deoxyguanosine and Their Use for Solid-Phase Synthesis of Oligodeoxynucleotides Containing 2', 5'-Phosphodiester Linkages
JPS61291595A (en) Production of 2&#39;-0-methylated rna
JPS62255499A (en) Fluorescent nucleoside or nucleotide
JPS59502025A (en) Method for producing oligonucleoside phosphonates
JPH02264792A (en) Oligonucleotide derivative and synthetic raw material thereof
JPS5993100A (en) Oligonucleotide derivative and its preparation
WO2023099471A1 (en) Method for producing polynucleotides
AU2002325599B2 (en) Oligonucleotide analogues
JP2025510019A (en) Methods and Compounds
CN107473972B (en) Nucleoside protective group and preparation thereof
CN117924393A (en) Monomer of 3&#39; -mercapto nucleoside analogue and its synthesis process
JPS6296497A (en) Production of ribooligonucleotide
JPS6363694A (en) Nucleoside phosphorothioite, synthesis thereof and production of oligonucleotide using said phosphorothioite
JPH0798834B2 (en) Fluorescent polynucleotide